Baris Guzel has been promoted to principal at BMW i Ventures, almost two years after joining the unit as a senior associate.
Month: January 2019
Ablative meets mystery corporate for $77m round
Medical device developer Ablative Solutions has closed the first tranche of its series D round having secured an undisclosed corporate backer.
Sheba Medical seeks $45m for Triventures fund
The healthcare provider’s Arc Innovation Center will invest in care-focused technologies through the fund, which is managed by venture firm Triventures.
Oculis eyes Nan Fung to boost series B
Investors including Nan Fung and Tekla Capital have increased the ophthalmic treatment developer’s series B round to $35.9m, following a Novartis-led tranche a year ago.
Jinda Nano produces series B round
Xiamen C&D has taken part in a $29.1m round for Jinda Nano Tech that will fuel the antibacterial product maker’s research into nanotechnology.
Tiburio takes home $31m
Lundbeckfonden Ventures and Alexandria Venture Investments both backed a series A round for tumour and endocrine disease drug developer Tiburio.
News round up 7 January 2019
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Zeaske seeks out Echo Health position
GE Ventures’ director of healthcare investments, Jessica Zeaske, has left for a partner role at corporate-backed investment vehicle Echo Health Ventures.
Immusoft hardens up $20m series B
Alexandria Venture Investments has taken part in the final close of the series B round, which will fund development of the company’s cell therapy platform.
NetEase tops up Second Dinner with $30m
NetEase has invested $30m in the game studio that will be used to hire staff and develop a debut game that will be released in partnership with Marvel.
Editorial: why private market strategies are outperforming public ones
The astonishing development of the private capital markets for fast-growing companies in the past five years is easy to record but it is only when put against public markets does the transformation in liquidity become apparent. In 2018 GCV Analytics tracked 2,775 deals worth an estimated $180.17bn of total capital raised (see more in our… Continue reading Editorial: why private market strategies are outperforming public ones
Exonate executes additional funding
Martlet has reinvested in Exonate through a $1.8m funding round that increased the retinal eye drop maker’s total funding to more than $11m.
Corporate venturing deal net: 24 December 2018-4 January 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
HJB finds MabSpace in merger deal
Eli Lilly-backed biotech companies HJB and MabSpace have agreed to merge into a newly formed business called Transcenta.